The global breast biopsy market is expected to reach $911 million by 2024, according to a new report from Grand View Research.
The market was valued at $373 million in 2015, the company said. North America has the largest market share, followed by Europe, and mammography-guided stereotactic biopsies are most common, followed by MRI-guided procedures. In terms of test type, needle-based biopsies account for the largest market share, according to the firm.
Going forward, the Asia-Pacific region will see the most growth, with a compound annual growth rate of 12.6% during the forecast period (2013 to 2024), Grand View Research said.
